SBI Term Loan: RLLR: 8.15 | 7.25% - 8.55%
Canara Bank: RLLR: 8 | 7.15% - 9.85%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.35% - 10.75%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 7.35% - 9.6%
IndusInd Bank: RLLR: -- | 7.6% - 10%
Bank of Maharashtra: RLLR: 8.05 | 7% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%
HDFC Bank: RLLR: -- | 7.75% - 13.2%
Axis Bank: RLLR: -- | 8% - 9.1%
IDBI Bank: RLLR: -- | 7.4% - 10%

AstraZeneca opens 25,600 sq ft corporate office in Mumbai, inaugurated by Fadnavis

#Taxation & Finance News#Commercial#India#Maharashtra#Mumbai City
Synopsis

Pharma major AstraZeneca has opened a 25,600 sq ft corporate office in Mumbai, inaugurated by Maharashtra Chief Minister Shri Devendra Fadnavis, according to a company statement. The company employs 5,000 people in India and has introduced more than 25 new medicines and indications in the country over the past three years. The company described the office as a commercial base to work closely with healthcare stakeholders across oncology, biopharmaceuticals and rare diseases. The opening adds to demand for office space in the city, where leasing data present a mixed picture this year.

Global pharma major AstraZeneca has opened a 25,600 sq ft corporate office in the financial capital, according to a statement. The office of the company, which employs 5,000 people in India and introduced over 25 new medicines and indications in the country over the last three years, was inaugurated by Maharashtra Chief Minister Shri Devendra Fadnavis on Friday. The company said the new office would be its commercial office in Mumbai. AstraZeneca Pharma India Limited also told stock exchanges about the opening, describing it as an extension of the company's presence in India. The statement did not give the lease terms, the building's location within the city or the number of employees who will work there. 
The company said it is currently conducting around 80 global clinical trials in India. It said the Mumbai office is expected to support closer engagement with healthcare stakeholders, the development of its people and collaboration across its key therapy areas in India, which are oncology, biopharmaceuticals and rare diseases. The company said the office would also support its efforts to expand access to innovative medicines. Fadnavis said Maharashtra has a strong and growing pharmaceutical and life sciences ecosystem, supported by skilled talent, leading institutions and robust healthcare infrastructure, and that AstraZeneca's decision to set up its India commercial office in Mumbai reflects confidence in the state's capabilities and its potential as an innovation hub. 
According to a separate report by UNI, Fadnavis said he was pleased to know that AstraZeneca's headquarters had earlier been in Bengaluru and was now in Mumbai. The company has not given details of how many functions have moved. An AstraZeneca executive said the new commercial office in Mumbai will support closer engagement with stakeholders and the continued development of the company's people, strengthening India's contribution to its regional and global ambition. At 25,600 sq ft, it is a relatively small office compared with the large campuses that some technology and services firms lease. The company did not say whether it plans to expand the space in the future. 
Mumbai's office market has been mixed this year. Knight Frank India said office leasing in Mumbai rose to 9.9 million sq ft in January to September from 7.4 million sq ft a year earlier, while Cushman & Wakefield's separate measure of net leasing showed Mumbai falling 46 per cent to 4.1 million sq ft. Both consultants have credited global capability centres and large corporate occupiers for demand in India's office markets. Mumbai-based developer SILA Properties also said this month that it plans to invest INR 500 crore over two years in land and projects, including commercial schemes in central and secondary business districts of the city. 
Source PTI

Discussion

Have something to say? Post your comment